CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-12 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion 10b5-1 | +10,000 | $36.75 | $368K | 49,502.69 |
| 2024-01-12 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −10,000 | $75.67 | $757K | 39,502.69 |
| 2024-01-12 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −10,000 | 38,000 | ||
| 2024-01-05 | MUSSALLEM MICHAEL A Director | Exercise or conversion 10b5-1 | +29,350 | $36.75 | $1.1M | 33,835.82 |
| 2024-01-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −2,500 | $73.46 | $184K | 31,335.82 |
| 2024-01-05 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −26,850 | $72.94 | $2.0M | 4,485.82 |
| 2024-01-05 | MUSSALLEM MICHAEL A Director | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −29,350 | 117,400 | ||
| 2023-12-29 | Ullem Scott B. CVP, Chief Financial Officer | Exercise or conversion 10b5-1 | +14,510 | $36.75 | $533K | 33,758 |
| 2023-12-29 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −14,510 | $76.55 | $1.1M | 19,248 |
| 2023-12-29 | Ullem Scott B. CVP, Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −14,510 | 29,015 | ||
| 2023-12-15 | Chopra Daveen CVP, TMTT | Exercise or conversion | +7,000 | $59.26 | $415K | 30,950 |
| 2023-12-15 | Chopra Daveen CVP, TMTT | Sale | −7,000 | $78.25 | $548K | 23,950 |
| 2023-12-15 | Chopra Daveen CVP, TMTT | Exercise or conversion · Employee Stock Option (Right to Acquire) | −7,000 | 7,000 | ||
| 2023-12-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion 10b5-1 | +8,000 | $36.75 | $294K | 47,502.69 |
| 2023-12-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −8,000 | $71.86 | $575K | 39,502.69 |
| 2023-12-13 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −8,000 | 48,000 | ||
| 2023-12-13 | Wood Larry L Global President TAVR & Surg | Exercise or conversion 10b5-1 | +8,658 | $45.28 | $392K | 222,451.71 |
| 2023-12-13 | Wood Larry L Global President TAVR & Surg | Sale 10b5-1 | −8,658 | $71.86 | $622K | 213,793.71 |
| 2023-12-13 | Wood Larry L Global President TAVR & Surg | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −8,658 | 0 | ||
| 2023-12-13 | MUSSALLEM MICHAEL A Director | Exercise or conversion 10b5-1 | +29,350 | $36.75 | $1.1M | 33,835.82 |
Page 31 of 43 · 841 trades